rs556924343

Variant summary

Our verdict is . The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001013653.3(LRRC26):​c.641C>G​(p.Ala214Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,264,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

LRRC26
NM_001013653.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.658

Publications

0 publications found
Variant links:
Genes affected
LRRC26 (HGNC:31409): (leucine rich repeat containing 26) Enables potassium channel activator activity; transmembrane transporter binding activity; and voltage-gated potassium channel activity. Involved in positive regulation of voltage-gated potassium channel activity and potassium ion transmembrane transport. Is integral component of plasma membrane. Part of voltage-gated potassium channel complex. [provided by Alliance of Genome Resources, Apr 2022]
MIR3621 (HGNC:38930): (microRNA 3621) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001013653.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.036).
BS2
High AC in GnomAdExome4 at 24 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001013653.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRC26
NM_001013653.3
MANE Select
c.641C>Gp.Ala214Gly
missense
Exon 1 of 2NP_001013675.1Q2I0M4-1
MIR3621
NR_037416.1
n.-33C>G
upstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRC26
ENST00000371542.3
TSL:1 MANE Select
c.641C>Gp.Ala214Gly
missense
Exon 1 of 2ENSP00000360597.3Q2I0M4-1
ENSG00000261793
ENST00000568665.1
TSL:3
c.*28-118C>G
intron
N/AENSP00000480768.1A0A087WX66
MIR3621
ENST00000580529.1
TSL:6
n.-33C>G
upstream_gene
N/A

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
0.0000190
AC:
24
AN:
1264130
Hom.:
0
Cov.:
30
AF XY:
0.0000258
AC XY:
16
AN XY:
620556
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24726
American (AMR)
AF:
0.00
AC:
0
AN:
15888
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27536
South Asian (SAS)
AF:
0.0000158
AC:
1
AN:
63446
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31538
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3812
European-Non Finnish (NFE)
AF:
0.0000224
AC:
23
AN:
1024670
Other (OTH)
AF:
0.00
AC:
0
AN:
52072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
12
DANN
Benign
0.89
DEOGEN2
Benign
0.011
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.064
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.66
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.036
Sift
Benign
0.38
T
Sift4G
Benign
0.39
T
Varity_R
0.062
gMVP
0.20
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.